Development and Implementation of Electronic Decision Aids for Genetic Testing in Inherited Cancer Syndromes
NCT ID: NCT04704193
Last Updated: 2024-08-13
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
93 participants
INTERVENTIONAL
2020-11-20
2023-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Genetic Risk: Whether, When, and How to Tell Adolescents
NCT03421327
Evaluation of a Decision Aid for Incidental Genomic Findings
NCT03244202
Educational Video for Genetic Testing
NCT05472714
Refining Information Technology Support for Genetics in Medicine
NCT01225978
Patient and Healthcare Professional Views on Genetic/Genomic Information and Testing
NCT04733274
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Electronic Decision Aid
Participants in this arm will complete an electronic decision aid for genetic testing.
Survey of Decision Aid
The decision aid will be evaluated by a survey administered to those who have used the tool.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Survey of Decision Aid
The decision aid will be evaluated by a survey administered to those who have used the tool.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosed with malignant ovarian tumor or malignant pancreatic adenocarcinoma
Exclusion Criteria
* Unable to complete surveys
* Previous germline genetic testing
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Boston Medical Center
OTHER
National Cancer Institute (NCI)
NIH
Massachusetts General Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Daniel C Chung
Daniel C Chung, MD; Director, High-Risk GI Cancer Clinic
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Daniel C Chung, MD
Role: PRINCIPAL_INVESTIGATOR
Massachusetts General Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Massachusetts General Hospital
Boston, Massachusetts, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol
Document Type: Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2020P003422
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.